Cutler Group’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-900
Closed -$29K 5141
2018
Q4
$29K Sell
900
-1,400
-61% -$213K ﹤0.01% 1855
2018
Q3
$34K Hold
2,300
﹤0.01% 1875
2018
Q2
$52K Sell
2,300
-9,100
-80% -$1.37M ﹤0.01% 1592
2018
Q1
$9K Buy
11,400
+3,100
+37% +$330K ﹤0.01% 2920
2017
Q4
$43K Buy
8,300
+6,800
+453% +$567K ﹤0.01% 1992
2017
Q3
$5K Sell
1,500
-300
-17% -$23.3K ﹤0.01% 4479
2017
Q2
$7K Buy
+1,800
New +$99.7K ﹤0.01% 4604

Other funds holding LOXO

Cutler Group's LOXO Position: Q1 2019 in Review

Cutler Group sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 400 shares — an estimated $56K sold.

Cutler Group first reported a position in LOXO in Q2 2017 and held it in 6 quarters. The position peaked at $297K in Q3 2017. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Cutler Group reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Cutler Group sold 400 Loxo Oncology, Inc shares in Q1 2019, an estimated $56K.
  • Cutler Group first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 6 quarters.
  • Cutler Group's Loxo Oncology, Inc position peaked at $297K in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Cutler Group's 13F filing for Q1 2019, filed 10 May 2019.